← Leaderboards
Sarika U Peters
Vanderbilt University
$2,112,916
Attributed
$2,112,916
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $348.6K · FY2016–22$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,112,916 · 2
By mechanism
R01$1,655,216 · 1
R21$457,700 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Yuri F. Van Der Heijden$3,583,425
- Rocco George Gogliotti$3,490,212
- Craig Lindsley$38,671,033
- Martin J Blaser$21,444,118
- Janet S Carpenter$4,276,784
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingMutationQuality Of LifeBaseGenesLinkMethyl-Cpg-Binding Protein 2Rett SyndromeAffectPhenotypeClinical PracticeClinical AssessmentsClinical MarkersClinical PathsBoysCytokineFutureCognitionCessation Of LifeChemokine ReceptorChemokineBiomarker IdentificationFoundationsCd4 Positive T Lymphocytes
Grant awards (8)
Clinical validation of at-home methods of sleep assessment in Rett Syndrome$243,278
R21 · FY2022 · TR · contact PI
Clinical validation of at-home methods of sleep assessment in Rett Syndrome$214,422
R21 · FY2021 · TR · contact PI
Markers of Disease Progression in MECP2 Duplication Syndrome$326,638
R01 · FY2020 · HD · contact PI
Markers of Disease Progression in MECP2 Duplication Syndrome$326,643
R01 · FY2019 · HD · contact PI
Markers of Disease Progression in MECP2 Duplication Syndrome$326,652
R01 · FY2018 · HD · contact PI
Markers of Disease Progression in MECP2 Duplication Syndrome$326,662
R01 · FY2017 · HD · contact PI
Markers of Disease Progression in MECP2 Duplication Syndrome$303,341
R01 · FY2016 · HD · contact PI
Markers of Disease Progression in MECP2 Duplication Syndrome$45,280
R01 · FY2016 · HD · contact PI